PCT、TNF—α、IL-6在急性白血病化疗后粒缺期感染患者的表达被引量：6

下载PDF

导出

摘要目的：探讨降钙素原（Procalcitonin，PCT）、肿瘤坏死因子α（Tumornecrosis factor—α，TNF-α）、白介素-6（Interleu—kin-6，IL-6）在急性白血病化疗后粒缺感染中的应用价值。方法：采用免疫发光法测定35例急性白血病患者化疗后粒细胞缺乏期感染前后PCT、TNF—α、IL-6变化水平。结果：粒缺感染组的PCT、IL-6水平高于粒缺非感染组，差异有统计学意义；TNF-α水平在粒缺感染组与非感染组间无统计学差异。PCT及IL-6对粒缺感染诊断价值中等。结论：PCT及IL-6对急性白血病粒缺期合并感染有一定的临床应用价值。

作者牛国敏尹松梅张复华杨国雷凌奕文潘焕玉徐嘉瑜

机构地区南方医科大学附属南海医院

出处《中国伤残医学》 2016年第9期27-29,共3页 Chinese Journal of Trauma and Disability Medicine

关键词降钙素原肿瘤坏死因子-α 白介素-6 急性白血病感染

分类号 R552 [医药卫生—血液循环系统疾病]

引文网络
相关文献

参考文献6

1Viallon A, Pouzet V, Z6ni F, Tardy B, Guyomarch S, Lambert C,Page Y, Bertrand JC. [ Rapid diagnosis of the type of meningitis (bacterial or viral) by the assay of serum procalcitonin ]. Presse Med. 2000 Mar 25;29(11) :584 -8.
2French. Lin SG, Hou TY, Huang DH, He SY, Lin YD, Zhang LY, Hsieh PS. Role of procalcitonin in the diagnosis of severe infection in ped- iatric patients with fever and Neulropenia - a systemic review and meta - analysis. Pediatr Infect Dis J. 2012 Oct;31 (10) :e182 ~ 8.
3Phillips RS, Wade R, Lehm~eher T, Stewart LA, Sutton AJ. Sys- tematic review and meta~ analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutrepenic episodes in children and young people with cancer. BMC Med. 2012 Jan 18; 10:6.
4Casey LC. Role of cytokines in the pathogerlesis of cardiopulmonary -induced multisystem organ failure. Ann Thorac Surg. 1993 Nov; 56(5 Suppl) :$92 ~6.
5Panacek EA, Marshall JC, Albertson TE, Johnson DH, Johnson S, MacArthur RD, Miller M, Barchuk WT, Fischkoff S, Kaul M, Teoh L, Van Meter L, Daum L, Lemeshow S, Hicklin G, Doig C ; Monoclonal Anti -TNF: a Randomized Controlled Sepsis Study In- vestigators. Efficacy and safety of the monoclonal anti - tumor nec- rosis factor antibody F(ab') 2 fragment afelimomab in patients with severe sepsis and elevated interleukin - 6 levels. Grit Care Med. 2004 Nov-32(ll ) :2173 ~82.
6梁珺,张洲,徐元宏.TNF-α、IL-6、IL-10、VCAM-1、E-Selectin在真菌性血流感染中的作用[J].安徽医科大学学报,2013,48(1):47-50. 被引量：9

二级参考文献11

1Meunier F, Aoun M, Bitar N. Candidemia in immunocompro-mised patients[ J]. Clin Infect Dis, 1992 ,14( SI) :S120 -5.
2Krcmery V C Jr, Babela R. Candidemia in the surgical intensivecare unit[ J]. Clin Infect Dis,2002 ,34( 11) : 1537 - 8.
3Andaluz-Ojeda D, Bobillo F, Iglesias V,et al. A combined scoreof pro- and anti-inflammatory interleukins improves mortality pre-diction in severe sepsis[ J]. Cytokine,2012 ,57(3) :332 -6.
4Lei M G,Gao J J,Morrison D C,et al. Pathogenesis of sepsis:cur-rent concepts and emerging therapies [ J ]. Mo Med,2003 , 100.5):524 -9.
5Bernard G R, Artigas A,Brigham K L, et al. Report of the Ameri-can-European consensus conference on ARDS : definitions,mecha-nisms ,relevant outcomes, and clinical trial coordination. The Con-sensus Committee[ J]. Intensive Care Med, 1994,20 ( 3 ) : 225 -32.
6Gando S, Kameue T, Matsuda N,et al. Serial changes in neutro-phil-endothelial activation markers during the course of sepsis as-sociated with disseminated intravascular coagulation [ J ] . ThrombRes,2005,116(2) :91 -100.
7Presterl E, Lassnigg A, Mueller-Uri P, et al. Cytokines in sepsisdue to Candida albicans and in bacterial sepsis[ J]. Eur CytokineNetw, 1999,10(3) : 423 -30.
8Kurt A N,Aygun A D,Godekmerdan A,et al. Serum IL-1 beta,IL-6, IL-8 , and TNF-alpha levels in early diagnosis and managementof neonatal sepsis[ J]. Mediators Inflamm,2007 ,2007 :31397.
9Chi H W, Yang Y S,Shang S T, et al. Candida albicans versusnon-albicans bloodstream infections : the comparison of risk factorsand outcome [J]. J Microbiol Immunol Infect, 2011,44(5) :369-75.
10程中乐,管世鹤,沈继录.血标本致病菌的分离鉴定及药物敏感性分析[J].安徽医科大学学报,2010,45(4):587-588. 被引量：3